Page last updated: 2024-09-02

kt 5823 and adenosine-3',5'-cyclic phosphorothioate

kt 5823 has been researched along with adenosine-3',5'-cyclic phosphorothioate in 1 studies

Compound Research Comparison

Studies
(kt 5823)
Trials
(kt 5823)
Recent Studies (post-2010)
(kt 5823)
Studies
(adenosine-3',5'-cyclic phosphorothioate)
Trials
(adenosine-3',5'-cyclic phosphorothioate)
Recent Studies (post-2010) (adenosine-3',5'-cyclic phosphorothioate)
317059507047

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deth, RC; Sharma, A; Waly, M1

Other Studies

1 other study(ies) available for kt 5823 and adenosine-3',5'-cyclic phosphorothioate

ArticleYear
Protein kinase C regulates dopamine D4 receptor-mediated phospholipid methylation.
    European journal of pharmacology, 2001, Sep-14, Volume: 427, Issue:2

    Topics: Alkaloids; Benzophenanthridines; Carbazoles; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Methylation; Naphthalenes; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Phenanthridines; Phorbol 12,13-Dibutyrate; Phospholipids; Protein Kinase C; Receptors, Dopamine D2; Receptors, Dopamine D4; Thionucleotides; Tumor Cells, Cultured

2001